Published in Lancet on June 18, 1988
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care (2015) 1.12
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes. Diabetes Care (2016) 1.08
Pancreatic regulation of glucose homeostasis. Exp Mol Med (2016) 0.81
Intra-islet glucagon secretion and action in the regulation of glucose homeostasis. Front Physiol (2013) 0.79
Intranasal glucagon: a promising approach for treatment of severe hypoglycemia. J Diabetes Sci Technol (2014) 0.75
Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling. Mol Cell Biol (2017) 0.75
Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes. Br J Clin Pharmacol (2008) 0.75
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (1998) 5.75
Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nat New Biol (1973) 3.41
Relation of diabetic control to development of microvascular complications. Diabetologia (1978) 2.99
Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis (2004) 2.77
Glycaemic index methodology. Nutr Res Rev (2005) 2.47
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet (1998) 2.44
Early closure of European Pimagedine trial. Steering Committee. Safety Committee. Lancet (1997) 2.28
Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes (1976) 1.99
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. Diabetes Metab (1997) 1.82
Does energy intake underreporting involve all kinds of food or only specific food items? Results from the Fleurbaix Laventie Ville Santé (FLVS) study. Int J Obes Relat Metab Disord (2000) 1.78
Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab (1990) 1.64
Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab (2009) 1.56
Correlation between amount of carbohydrate in mixed meals and insulin delivery by artificial pancreas in seven IDDM subjects. Diabetes Care (1989) 1.50
Diabetic control in 102 insulin-treated out-patients. Diabetologia (1980) 1.47
[Practice guideline for the diagnosis, prevention, treatment of obesity in France. Groupe de Travail charge de la mise au point des "Recommandations pour le diagnostic, la prévention et le traitement des Obésités en France"]. Diabetes Metab (1998) 1.46
Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain (1983) 1.43
[Inter-disciplinary European guidelines on surgery of severe obesity]. Vnitr Lek (2008) 1.42
Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. N Engl J Med (1992) 1.41
Type I and type IV allergy to the insulin analogue detemir. Lancet (2007) 1.41
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia (2005) 1.33
Determinants and nature of dietary underreporting in a free-living population: the Fleurbaix Laventie Ville Santé (FLVS) Study. Int J Obes Relat Metab Disord (1997) 1.30
Non food-related environmental stimuli induce increased meal intake in healthy women: comparison of television viewing versus listening to a recorded story in laboratory settings. Appetite (2004) 1.28
Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) (2007) 1.19
Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab (2003) 1.19
Trends in the prevalence of obesity in the French adult population between 1980 and 1991. Int J Obes Relat Metab Disord (1999) 1.17
The risk of diabetic control: a comparison of hospital versus general practice supervision. Diabetologia (1982) 1.16
"Specific" scale compared with "generic" scale: a double measurement of the quality of life in a French community sample of obese subjects. J Epidemiol Community Health (1998) 1.16
Three cases of allergic reaction to human insulin. Lancet (1983) 1.14
A review of the metabolic syndrome. Diabetes Metab (2007) 1.12
Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr (2002) 1.11
Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment. Diabetes Metab (2007) 1.10
Indication for linkage of the human OB gene region with extreme obesity. Diabetes (1996) 1.10
Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes (1997) 1.09
Effects of long-term low-glycaemic index starchy food on plasma glucose and lipid concentrations and adipose tissue cellularity in normal and diabetic rats. Br J Nutr (1996) 1.09
Glycosylated haemoglobin concentrations and clinitest results in insulin-dependent diabetes. Lancet (1977) 1.09
Gender differences in the relation between food cravings and mood in an adult community: Results from the fleurbaix laventie ville santé study. Int J Eat Disord (2001) 1.07
Serial postprandial plasma insulin levels in 117 subjects with and without diabetes. Diabetes (1973) 1.06
Candidate gene approach of familial morbid obesity: linkage analysis of the glucocorticoid receptor gene. Int J Obes Relat Metab Disord (1996) 1.05
A polymorphism in the 5' untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord (1998) 1.04
The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet Med (1992) 1.04
A high glycemic index starch diet affects lipid storage-related enzymes in normal and to a lesser extent in diabetic rats. J Nutr (1998) 1.04
Dietary amylose-amylopectin starch content affects glucose and lipid metabolism in adipocytes of normal and diabetic rats. J Nutr (1998) 1.03
One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes (1974) 1.02
Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab (2009) 1.01
Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients. Diabetologia (1983) 1.01
Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia (2002) 1.00
The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solutin, or gel for the correction of insulin reactions. Arch Intern Med (1990) 0.99
Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care (1989) 0.99
Macronutrient energy intake and adiposity in non obese prepubertal children aged 5-11 y (the Fleurbaix Laventie Ville Santé Study). Int J Obes Relat Metab Disord (2000) 0.98
Sucrose taken during mixed meal has no additional hyperglycaemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet (1984) 0.98
The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord (1995) 0.97
Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr (2000) 0.97
Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychol Med (2010) 0.97
Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Diabetes (1981) 0.97
Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities. Diabetes Metab (2013) 0.96
Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med (1991) 0.96
Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr (1996) 0.96
Additive effect of A-->G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord (1996) 0.96
Glucagon antibodies. Lancet (1965) 0.95
Leisure-time and occupational physical activity in relation to cardiovascular risk factors and eating habits in French adults. Public Health Nutr (2006) 0.95
French cross-cultural adaptation of the Health Utilities Indexes Mark 2 (HUI2) and 3 (HUI3) classification systems. Clinical and Economic Working Groups. Qual Life Res (1998) 0.93
eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med (2002) 0.93
Delayed progression of diabetic retinopathy by divided insulin administration: a further follow-up. Diabetologia (1979) 0.92
Dual x-ray absorptiometry, bioelectrical impedance, and near infrared interactance in obese women. Med Sci Sports Exerc (2001) 0.92
Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids. J Nutr (1996) 0.92
Effects of dietary propionate on hepatic glucose production, whole-body glucose utilization, carbohydrate and lipid metabolism in normal rats. Br J Nutr (1995) 0.91
Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes (2000) 0.91
Serial postprandial blood glucose levels in 309 subjects with and without diabetes. Diabetes (1973) 0.91
Satiating effect of proteins in healthy subjects: a comparison of egg albumin, casein, gelatin, soy protein, pea protein, and wheat gluten. Am J Clin Nutr (1998) 0.91
Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Metab Disord (1997) 0.90
Recommendations for the diagnosis, the prevention and the treatment of obesity. Diabetes Metab (2002) 0.90
Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats. Br J Nutr (1993) 0.89
Recommendations regarding obesity surgery. Obes Surg (2005) 0.89
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene. Am J Hum Genet (1990) 0.89
Obesity morbidity and health care costs in France: an analysis of the 1991-1992 Medical Care Household Survey. Int J Obes Relat Metab Disord (2000) 0.88
[Prevalence of obesity in adults in France: the situation in 2000 established from the OBEPI Study]. Ann Endocrinol (Paris) (2002) 0.88
Menopause, fat and lean distribution in obese women. Maturitas (1996) 0.87
Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Eur J Clin Nutr (1999) 0.87
Weight gain at the time of menopause. Hum Reprod (1997) 0.87
Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care (1998) 0.87
Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study. Int J Obes (1988) 0.87